1. Costa SM, Martins CC, Bonfim Mde
L, Zina LG, Paiva SM, Pordeus
IA, Abreu MH: A
systematic review of socioeconomic indicators and
dental caries in adults. Int
J Environ Res Public Health. 2012;9:3540-74.
https://doi.org/10.3390/ijerph9103540
PMid:23202762 PMCid:PMC3509471
|
|
2. Lenander-Lumikari M, Loimaranta V. Saliva and dental
caries. Adv Dent Res.
2000;14:40-7.
https://doi.org/10.1177/08959374000140010601
PMid:11842922
|
|
|
3. Kirstilä
V, Häkkinen P, Jentsch H, Vilja
P, Tenovuo J.
Longitudinal analysis of the association of human
salivary anti-microbial agents with caries
increment and cariogenic
micro-organisms: A two-year cohort study. J
Dent Res. 1998;77:73-80.
https://doi.org/10.1177/00220345980770011101
PMid:9437402
|
|
|
4. Rudney
JD. Saliva and dental plaque. Adv Dent Res.
2000;14:29-39.
https://doi.org/10.1177/08959374000140010401
PMid:11842921
|
|
|
5. Humphrey SP, Williamson
RT. A review of saliva: normal composition, flow,
and function. J Prosthet
Dent. 2001;85:162-9.
https://doi.org/10.1067/mpr.2001.113778
PMid:11208206
|
|
|
6. Bergandi
L, Defabianis P, Re F, Preti G, Aldieri
E, Garetto S, Bosia A, Ghigo
D. Absence of soluble CD14 in saliva of young
patients with dental caries. Eur
J Oral Sci. 2007;115:93-6.
https://doi.org/10.1111/j.1600-0722.2007.00437.x
PMid:17451497
|
|
|
7. Lein
E, Ingalls RR. Toll-like receptors. Crit Care Med. 2002;30: S1-S11.
https://doi.org/10.1097/00003246-200201001-00001
|
|
|
8. Zhao A, Blackburn C,
Chin J, Srinivasan M.
Soluble toll like receptor 2 (TLR-2) is increased
in saliva of children with dental caries. BMC Oral
Health. 2014;14:108.
https://doi.org/10.1186/1472-6831-14-108
PMid:25174416 PMCid:PMC4236648
|
|
|
9. Biria
M, Sattari M, Vahid Golpayegani
M, Kooshki F. Association
of salivary sCD14 concentration levels with early
childhood caries. Iran
J Immunol. 2010;7:193-7.
PMid:20876990
|
|
|
10. WHO oral health
surveys. WHO 4th edition 1997.
|
|
|
11. Navazesh M, Kumar SK; University of Southern
California School of Dentistry. Measuring salivary flow:
Challenges and opportunities J Am Dent Assoc.
2008;139;35S-40S.
https://doi.org/10.14219/jada.archive.2008.0353
PMid:18460678
|
|
|
12. Bas S, Gauthier BR, Spenato U, Stingelin
S, Gabay C. CD14 is an
acute-phase protein. J Immunol. 2004;172:4470-9.
https://doi.org/10.4049/jimmunol.172.7.4470
PMid:15034063
|
|
|
13. Krüger C, Schütt C, Obertacke U, Joka T, Müller FE, Knöller J, et al. Serum CD14 levels
in polytraumatized and
severely burned patients. Clin
Exp Immunol 1991;85:297-301.
https://doi.org/10.1111/j.1365-2249.1991.tb05722.x
PMid:1713813 PMCid:PMC1535761
|
|
|
14. Horneff
G, Sack U, Kalden JR, Emmrich F, Burmester
GR. Reduction of monocyte-macrophage
activation markers upon anti-CD4 treatment:
decreased levels of IL-1, IL-6, neopterin
and soluble CD14 in patients with rheumatoid
arthritis. Clin Exp Immunol. 1993;91:207-13.
https://doi.org/10.1111/j.1365-2249.1993.tb05884.x
PMid:7679058 PMCid:PMC1554673
|
|
|
15. Nockher
WA, Wigand R, Schoeppe W,
Scherberich JE. Elevated
levels of soluble CD14 in serum of patients with
systemic lupus erythematosus.
Clin Exp Immunol. 1994;96:15-9.
https://doi.org/10.1111/j.1365-2249.1994.tb06222.x
PMid:7512005 PMCid:PMC1534537
|
|
|
16. Landmann
R, Zimmerli W, Sansano S et al. Increased
circulating soluble CD14 is associated with high
mortality in gram-negative septic shock. J Infect
Dis. 1995;171: 639–644.
https://doi.org/10.1093/infdis/171.3.639
PMid:7533199
|
|
|
17. Lawn SD, Labeta MO, Arias M, Acheampong JW, Griffin GE.
Elevated serum concentrations of soluble CD14 in
HIV) and HIV+ patients with tuberculosis in Africa:
prolonged elevation during anti-tuberculosis
treatment. Clin Exp Immunol. 2000;120: 483-7.
https://doi.org/10.1046/j.1365-2249.2000.01246.x
PMid:10844527 PMCid:PMC1905566
|
|
|
18. Jin L, Davverau RP. Soluble CD14
levels in gingival crevicular
fluid of subjects with untreated adult periodontitis. J Periodontol.
2001;72:634-40.
https://doi.org/10.1902/jop.2001.72.5.634
PMid:11394399
|
|
|
19. Pugin
J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation
of human endothelial and epithelial cells is
mediated by lipopolysaccharide-binding
protein and soluble CD14. Proc
Natl Acad
Sci USA. 1993:90:2744-8.
https://doi.org/10.1073/pnas.90.7.2744
PMid:7681988 PMCid:PMC46172
|
|
|
20. Sugawara S, Uehara
A, Tamai R, Takada H. Innate
immune responses in oral
mucosa. J Endotoxin Res
2002;8:465-8.
https://doi.org/10.1177/09680519020080060201
PMid:12697091
|
|